162 related articles for article (PubMed ID: 15464833)
21. Development of simulated intestinal fluids containing nutrients as transport media in the Caco-2 cell culture model: assessment of cell viability, monolayer integrity and transport of a poorly aqueous soluble drug and a substrate of efflux mechanisms.
Lind ML; Jacobsen J; Holm R; Müllertz A
Eur J Pharm Sci; 2007 Dec; 32(4-5):261-70. PubMed ID: 17890067
[TBL] [Abstract][Full Text] [Related]
22. Investigation of archaeosomes as carriers for oral delivery of peptides.
Li Z; Chen J; Sun W; Xu Y
Biochem Biophys Res Commun; 2010 Apr; 394(2):412-7. PubMed ID: 20226174
[TBL] [Abstract][Full Text] [Related]
23. Permeability enhancing effects of the alkylglycoside, octylglucoside, on insulin permeation across epithelial membrane in vitro.
Tirumalasetty PP; Eley JG
J Pharm Pharm Sci; 2006; 9(1):32-9. PubMed ID: 16849006
[TBL] [Abstract][Full Text] [Related]
24. Improvement of the intestinal membrane permeability of low molecular weight heparin by complexation with stem bromelain.
Grabovac V; Bernkop-Schnürch A
Int J Pharm; 2006 Dec; 326(1-2):153-9. PubMed ID: 16950580
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Caco-2 cell monolayer drug transport properties by cassette dosing using UV/fluorescence HPLC.
Palmgrén JJ; Mönkkönen J; Jukkola E; Niva S; Auriola S
Eur J Pharm Biopharm; 2004 Mar; 57(2):319-28. PubMed ID: 15018991
[TBL] [Abstract][Full Text] [Related]
26. [Using chamber technique for studying the permeability of dexamethasone sodium phosphate liposome through rabbit colon mucosa in vitro].
Li GF; Chen JH; Yang J; Guo D; Ren F; Wang CX; Hou LB
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):11-4. PubMed ID: 14724084
[TBL] [Abstract][Full Text] [Related]
27. Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium.
Kamei N; Aoyama Y; Khafagy el-S; Henmi M; Takeda-Morishita M
Eur J Pharm Biopharm; 2015 Aug; 94():42-51. PubMed ID: 25960330
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
29. Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model.
Tian XJ; Yang XW; Yang X; Wang K
Int J Pharm; 2009 Feb; 367(1-2):58-64. PubMed ID: 18848870
[TBL] [Abstract][Full Text] [Related]
30. [Oral administration of insulin by means of liposomes in animal experiments (author's transl)].
Tragl KH; Pohl A; Kinast H
Wien Klin Wochenschr; 1979 Jun; 91(13):448-51. PubMed ID: 463043
[TBL] [Abstract][Full Text] [Related]
31. Prolactin-stimulated transepithelial calcium transport in duodenum and Caco-2 monolayer are mediated by the phosphoinositide 3-kinase pathway.
Jantarajit W; Thongon N; Pandaranandaka J; Teerapornpuntakit J; Krishnamra N; Charoenphandhu N
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E372-84. PubMed ID: 17488805
[TBL] [Abstract][Full Text] [Related]
32. [Study on absorption mechanism of puerarin and its nanoparticles across Caco-2 cell model].
Liu XJ; Jia Q; Wang CY; Wang NL
Zhong Yao Cai; 2009 Aug; 32(8):1252-5. PubMed ID: 19960950
[TBL] [Abstract][Full Text] [Related]
33. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
Hombach J; Hoyer H; Bernkop-Schnürch A
Eur J Pharm Sci; 2008 Jan; 33(1):1-8. PubMed ID: 17980561
[TBL] [Abstract][Full Text] [Related]
34. Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs.
Lim CJ; Shen WC
J Control Release; 2005 Sep; 106(3):273-86. PubMed ID: 15964654
[TBL] [Abstract][Full Text] [Related]
35. Complexation hydrogels for oral protein delivery: an in vitro assessment of the insulin transport-enhancing effects following dissolution in simulated digestive fluids.
Perakslis E; Tuesca A; Lowman A
J Biomater Sci Polym Ed; 2007; 18(12):1475-90. PubMed ID: 17988515
[TBL] [Abstract][Full Text] [Related]
36. [Absorption of papaverine, laudanosine and cepharanthine across human intestine by using human Caco-2 cells monolayers model].
Ma L; Yang XW
Yao Xue Xue Bao; 2008 Feb; 43(2):202-7. PubMed ID: 18507350
[TBL] [Abstract][Full Text] [Related]
37. [Absorption of triterpenoid compounds from Indian bread (Poria cocos) across human intestinal epithelial (Caco-2) cells in vitro].
Zheng Y; Yang XW
Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(13):1596-601. PubMed ID: 18837324
[TBL] [Abstract][Full Text] [Related]
38. Comparison of different intestinal epithelia as models for absorption enhancement studies.
Legen I; Salobir M; Kerc J
Int J Pharm; 2005 Mar; 291(1-2):183-8. PubMed ID: 15707745
[TBL] [Abstract][Full Text] [Related]
39. Investigation of regional mechanisms responsible for poor oral absorption in humans of a modified release preparation of the alpha-adrenoreceptor antagonist, 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): the rational use of ex vivo intestine to predict in vivo absorption.
Collett A; Stephens RH; Harwood MD; Humphrey M; Dallman L; Bennett J; Davis J; Carlson GL; Warhurst G
Drug Metab Dispos; 2008 Jan; 36(1):87-94. PubMed ID: 17932223
[TBL] [Abstract][Full Text] [Related]
40. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.
Fossati L; Dechaume R; Hardillier E; Chevillon D; Prevost C; Bolze S; Maubon N
Int J Pharm; 2008 Aug; 360(1-2):148-55. PubMed ID: 18539418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
